HER2 mutation status in Japanese HER2-positive breast cancer patients.
Endo Y, Dong Y, Kondo N, Yoshimoto N, Asano T, Hato Y, Nishimoto M, Kato H, Takahashi S, Nakanishi R, Toyama T.
Endo Y, et al. Among authors: yoshimoto n.
Breast Cancer. 2016 Nov;23(6):902-907. doi: 10.1007/s12282-015-0659-y. Epub 2015 Dec 7.
Breast Cancer. 2016.
PMID: 26642960